Applied Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
04 Feb 2026	Form 4: Kanter Stacy J., Director Returned 22,500 shares to the issuer · Disposed of 42,500 shares (Tender Offer) · Disposed of 263,690 Stock Option (Right to Buy) (Disposition to Issuer)
03 Feb 2026	Form 4: Hooks Corwin Dale, Chief Commercial Officer Received 312,500 shares as a grant or award · Returned 862,500 shares to the issuer · Disposed of 5,753 shares (Tender Offer)
03 Feb 2026	Form 4: Chinoporos Constantine, See Remarks Received 437,500 shares as a grant or award · Returned 1,000,000 shares to the issuer · Disposed of 57,111 shares (Tender Offer)
03 Feb 2026	Form 4: Skyler Jay S, Director Returned 22,500 shares to the issuer · Disposed of 42,500 shares (Tender Offer) · Disposed of 263,690 Stock Option (Right to Buy) (Disposition to Issuer)
03 Feb 2026	Form 4: Funtleyder Leslie D., Director Received 1,187,500 shares as a grant or award · Returned 2,375,000 shares to the issuer · Disposed of 152,959 shares (Tender Offer) · 1 more
03 Feb 2026	Form 4: Bailey Evan Prescott, Chief Medical Officer Received 437,500 shares as a grant or award · Returned 1,235,915 shares to the issuer · Disposed of 60,901 shares (Tender Offer) · 1 more
03 Feb 2026	Form 4: Lerner Teena, Director Returned 22,500 shares to the issuer · Disposed of 82,922 shares (Tender Offer) · Disposed of 287,631 Stock Option (Right to Buy) (Disposition to Issuer)
02 Jan 2026	Form 4: Funtleyder Leslie D., Director Received 150,000 shares as a grant or award
18 Dec 2025	Form 4: Kanter Stacy J., Director Sold 43,000 shares ($4.82K)
01 Oct 2025	Form 4: Funtleyder Leslie D., Director Received 150,000 shares as a grant or award
03 Jul 2025	Form 4: Funtleyder Leslie D., Director Received 150,000 shares as a grant or award · Received 150,000 shares as a grant or award
17 Jun 2025	Form 4: Bailey Evan Prescott, Chief Medical Officer Received 300,000 shares as a grant or award
11 Jun 2025	Form 4: Lerner Teena, Director Granted 200,000 Stock Option (Right to Buy)
11 Jun 2025	Form 4: Kanter Stacy J., Director Granted 200,000 Stock Option (Right to Buy)
11 Jun 2025	Form 4: Skyler Jay S, Director Granted 200,000 Stock Option (Right to Buy)
26 Mar 2025	Form 4: Hooks Corwin Dale, Chief Commercial Officer Received 250,000 shares as a grant or award
26 Mar 2025	Form 4: Funtleyder Leslie D., Director Received 350,000 shares as a grant or award
26 Mar 2025	Form 4: Chinoporos Constantine, See Remarks Received 350,000 shares as a grant or award
06 Mar 2025	Form 4: Perfetti Riccardo, Chief Medical Officer Sold 10,366 shares ($4.56K)
06 Mar 2025	Form 4: Funtleyder Leslie D., Director Sold 14,502 shares ($6.38K)

Comments